3D Systems (DDD) Q4 2025 earnings summary

Executive summary

• Achieved a strong Q4 2025 finish with 16% sequential revenue growth, driven by new printer sales, materials, and momentum in aerospace & defense, personalized health services (PHS), and dental markets.

• Focused on R&D investment, operational discipline, and cost savings, delivering $55M in annualized savings in 2025.

• Divested Geomagic software business in April 2025, impacting year-over-year comparisons.

• Recognized innovation in 3D-printed human lung and expanded U.S. facility to support aerospace & defense growth.

• Net loss for Q4 narrowed significantly year-over-year, mainly due to gains on disposition and lower operating expenses.

Financial highlights

• Q4 2025 consolidated revenue was $106.3M, up 3% year-over-year (adjusted for Geomagic), and up 16% sequentially from Q3.

• Full year 2025 revenue was $386.9M, down 7% year-over-year (adjusted for Geomagic).

• Q4 non-GAAP gross margin was 31%; full year non-GAAP gross margin was 34.3%.

• Q4 adjusted EBITDA loss was $5.3M, a significant improvement year-over-year (adjusted for Geomagic).

• Ended Q4 with $97.1M in total cash.

Outlook and guidance

• Q1 2026 revenue expected between $91M–$94M; adjusted EBITDA loss of $5M–$3M.

• Aerospace & defense expected to grow over 20% in 2026; PHS and dental segments also forecasted for continued growth.

• Limiting guidance to Q1 2026 due to geopolitical and macroeconomic uncertainties.